Manfred Lehmann

1.6k total citations
58 papers, 1.4k citations indexed

About

Manfred Lehmann is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Manfred Lehmann has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 20 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Manfred Lehmann's work include T-cell and B-cell Immunology (25 papers), Immune Cell Function and Interaction (22 papers) and Immunotherapy and Immune Responses (12 papers). Manfred Lehmann is often cited by papers focused on T-cell and B-cell Immunology (25 papers), Immune Cell Function and Interaction (22 papers) and Immunotherapy and Immune Responses (12 papers). Manfred Lehmann collaborates with scholars based in Germany, United States and Czechia. Manfred Lehmann's co-authors include Hans‐Dieter Volk, Angela Siegling, Thomas Ritter, Cornelia Platzer, Frank Emmrich, Jerzy W. Kupiec‐Weglinski, Birgit Sawitzki, E. Graser, Wayne W. Hancock and M H Sayegh and has published in prestigious journals such as The Journal of Immunology, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Manfred Lehmann

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manfred Lehmann Germany 19 699 406 347 267 237 58 1.4k
Joan Urmson Canada 24 886 1.3× 565 1.4× 277 0.8× 473 1.8× 143 0.6× 54 1.8k
Francis T. Thomas United States 26 454 0.6× 1.0k 2.5× 313 0.9× 275 1.0× 263 1.1× 49 1.7k
Michael Burg Netherlands 19 246 0.4× 410 1.0× 328 0.9× 208 0.8× 144 0.6× 62 1.5k
Hong Rae Cho South Korea 16 1.1k 1.6× 562 1.4× 344 1.0× 412 1.5× 200 0.8× 50 2.0k
P. B. Carroll United States 18 308 0.4× 743 1.8× 209 0.6× 345 1.3× 239 1.0× 66 1.6k
Nelson Goes United States 15 693 1.0× 791 1.9× 243 0.7× 846 3.2× 105 0.4× 31 2.0k
W. A. Buurman Netherlands 22 431 0.6× 390 1.0× 318 0.9× 64 0.2× 85 0.4× 43 1.6k
P G Beatty United States 13 922 1.3× 139 0.3× 330 1.0× 67 0.3× 151 0.6× 13 1.9k
Roy A. Dempsey United States 16 585 0.8× 206 0.5× 207 0.6× 106 0.4× 61 0.3× 30 1.1k
Yuka Tanaka Japan 25 706 1.0× 473 1.2× 262 0.8× 235 0.9× 122 0.5× 140 1.7k

Countries citing papers authored by Manfred Lehmann

Since Specialization
Citations

This map shows the geographic impact of Manfred Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Lehmann more than expected).

Fields of papers citing papers by Manfred Lehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Lehmann. The network helps show where Manfred Lehmann may publish in the future.

Co-authorship network of co-authors of Manfred Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Lehmann. A scholar is included among the top collaborators of Manfred Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Lehmann. Manfred Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hofmeyr, Ross, et al.. (2020). Assessment of continuous ventilation during tracheal dilatation using a novel, non-occlusive balloon in an ovine model. Southern African Journal of Anaesthesia and Analgesia. 26(5). 245–249. 1 indexed citations
2.
Vogt, Katrin, Christine Appelt, Anja A. Kühl, et al.. (2012). Permanent CNI Treatment for Prevention of Renal Allograft Rejection in Sensitized Hosts Can Be Replaced by Regulatory T Cells. American Journal of Transplantation. 12(9). 2384–2394. 28 indexed citations
3.
Langrehr, Jan M., Markus Hammer, Manfred Lehmann, et al.. (2007). Short-Term Anti-CD4 Plus Anti-TNF-α Receptor Treatment in Allogeneic Small Bowel Transplantation Results in Long-Term Survival. Transplantation. 84(5). 639–646. 11 indexed citations
4.
Kotsch, Katja, Josef Brock, Peter Nickel, et al.. (2004). FTY720 Prevents Anti-CD4 mAb-Induced Tolerance but Cannot Reverse Established Tolerance in a Rat Kidney Transplantation Model. American Journal of Transplantation. 4(6). 863–871. 6 indexed citations
5.
Ritter, Thomas, Manfred Lehmann, & Hans‐Dieter Volk. (2002). Improvements in Gene Therapy. BioDrugs. 16(1). 3–10. 77 indexed citations
6.
Lehmann, Manfred, Horst Nizze, Jens Lutz, et al.. (2002). Fumaric acid esters are potent immunosuppressants: inhibition of acute and chronic rejection in rat kidney transplantation models by methyl hydrogen fumarate. Archives of Dermatological Research. 294(9). 399–404. 17 indexed citations
7.
Sawitzki, Birgit, Manfred Lehmann, Katrin Vogt, et al.. (2002). Bag-1 up-regulation in anti-CD4 mAb-treated allo-activated T cell confers resistance to activation-induced cell death (AICD). Transplant Immunology. 9(2-4). 83–91. 4 indexed citations
8.
Zhai, Yuan, Xiu‐Da Shen, Manfred Lehmann, et al.. (2001). T Cell Subsets and In Vitro Immune Regulation in “Infectious” Transplantation Tolerance. The Journal of Immunology. 167(9). 4814–4820. 24 indexed citations
9.
Sawitzki, Birgit, Manfred Lehmann, Thomas Ritter, et al.. (2001). Regulatory tolerance-mediating T cells in transplantation tolerance. Transplantation Proceedings. 33(3). 2092–2093. 25 indexed citations
10.
Ke, Bibo, Thomas Ritter, Hirohisa Kato, et al.. (2000). Regulatory Cells Potentiate the Efficacy of IL-4 Gene Transfer by Up-Regulating Th2-Dependent Expression of Protective Molecules in the Infectious Tolerance Pathway in Transplant Recipients. The Journal of Immunology. 164(11). 5739–5745. 47 indexed citations
12.
Lehmann, Manfred, et al.. (1999). Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen. Transplantation Proceedings. 31(1-2). 1237–1238. 3 indexed citations
13.
Kuttler, Beate, et al.. (1999). Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies. Journal of Molecular Medicine. 77(1). 226–229. 8 indexed citations
14.
Lehmann, Manfred, et al.. (1999). Abolition of anti-CD4-induced allotransplantation tolerance by exogenous IL-2. Transplantation Proceedings. 31(1-2). 1220–1221. 3 indexed citations
15.
Becker, Gerold, E. Graser, H Nizze, et al.. (1997). Inhibition of chronic rejection after kidney transplantation by anti-CD4 treatment. Transplantation Proceedings. 29(1-2). 328–329. 2 indexed citations
17.
Lehmann, Manfred, E. Graser, Wayne W. Hancock, et al.. (1997). ANTI-CD4 MONOCLONAL ANTIBODY-INDUCED ALLOGRAFT TOLERANCE IN RATS DESPITE PERSISTENCE OF DONOR-REACTIVE T CELLS1. Transplantation. 64(8). 1181–1187. 62 indexed citations
18.
Onodera, K, Wayne W. Hancock, E. Graser, et al.. (1997). Th2-type cytokines in the “Infectious” tolerance pathway. Transplantation Proceedings. 29(1-2). 1290–1291. 5 indexed citations
19.
Lei, Dinghua, Manfred Lehmann, Judd E. Shellito, et al.. (1996). Nondepleting Anti-CD4 Antibody Treatment Prolongs Lung-Directed E1-Deleted Adenovirus-Mediated Gene Expression in Rats. Human Gene Therapy. 7(18). 2273–2279. 51 indexed citations
20.
Binder, Jochen, Manfred Lehmann, E. Graser, et al.. (1996). THE EFFECTS OF NONDEPLETING CD4 TARGETED THERAPY IN PRESENSITIZED RAT RECIPIENTS OF CARDIAC ALLOGRAFTS1,2. Transplantation. 61(5). 804–811. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026